Document is current
Any future updates will be listed below
-
Authors
Terheyden, Jan Henrik https://orcid.org/0000-0002-0174-4066
Pielka, Maren
Schneider, Tobias
Holz, Frank G.
Sifa, Rafet
- License Information
-
More Information
Article History
Received: 19 April 2024
Accepted: 13 March 2025
First Online: 24 March 2025
Declarations
:
: Not applicable.
: Not applicable.
: JHT: Heidelberg Engineering, Optos, Zeiss, CenterVue, Novartis, Okko. MP: None. TS: None. FGH: Allergan, Annexon, Alzheon, Apellis, Astellas, Bayer, Boehringer-Ingelheim, Bioeq/Formycon, CenterVue, Roche/Genentech, 4D Molecular Therapeuticcs, Geuder, Grayburg,, Heidelberg Engineering, IvericBio/Astellas, Janssen, LinBiosciences, NightStarX, Novartis, Optos, Oxurion, Pixium Vision, Stealth BioTherapeutics, Carl Zeiss Meditec, Grade Reading Center. RS: None.
